Good Chemistry? Beckman Will Acquire Olympus Diagnostics For $800 Mil.

Beckman Coulter's proposed $800 million acquisition of Tokyo-based Olympus Diagnostics would help grow its chemistry diagnostics portfolio and expand its global presence, the firm said Feb. 27